![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 9, 8324-8331, March 4, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2I Domain of Integrin
M
2*




¶
From the
Departments of
Physiology and
Biochemistry, University of Maryland School of Medicine, Rockville, Maryland 20855
Integrin activation has been postulated to occur in part via conformational changes in the I domain of the
subunit (the
I domain), especially near the F-
7 loop, in response to "inside-out" signaling. However, direct evidence for a role of the F-
7 loop in ligand binding and activity modulation is still lacking. Here, we report our finding that the F-
7 loop (residues 344358) within the
2I domain has dual functions in ligand binding by
M
2. On the one hand, it supports intercellular adhesion molecule 1 (ICAM-1) binding to
M
2 directly as part of a recognition interface formed by five noncontiguous segments (Pro192Glu197, Asn213Glu220, Leu225Leu230, Ser324Thr329, and Glu344Asp348) on the apex of the
2I domain. On the other hand, it controls the open and closed conformation of the
M
2 receptor, thereby indirectly affecting
M
2 binding to other ligands. Switching the five constituent sequences of the ICAM-1-binding site within the
2I domain to their
1 counterparts destroyed ICAM-1 binding but had no effect on the gross conformations of the receptor. Of the five ICAM-1 binding-defective mutants, four had normal or even stronger interaction with Fg and C3bi, as reported in our previous study. Synthetic peptides derived from the identified site inhibited
M
2-ICAM-1 interaction and supported direct binding to ICAM-1. Most importantly, perturbation of the F-
7 loop caused conformational changes within the
2I domain, which was further propagated to other regions of
M
2. Altogether, our data demonstrate that inside-out signaling could modulate ligand binding directly by changing the ligand-binding pocket per se and/or indirectly by inducing multiple conformational changes within the receptor.
Received for publication, December 1, 2004
* This work was supported in part by NHLBI, National Institute of Health Grant R01 HL61589-01 and by American Heart Association Grant 0240208N. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Physiology, University of Maryland School of Medicine, 15601 Crabbs Branch Way, Rockville, MD 20855. Tel.: 301-738-0657; Fax: 301-738-0465; E-mail: ZHANGL{at}USA.REDCROSS.ORG.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Zhu, B. Boylan, B.-H. Luo, P. J. Newman, and T. A. Springer Tests of the Extension and Deadbolt Models of Integrin Activation J. Biol. Chem., April 20, 2007; 282(16): 11914 - 11920. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gupta, A. Gylling, J. L. Alonso, T. Sugimori, P. Ianakiev, J.-P. Xiong, and M. Amin Arnaout The {beta}-tail domain ({beta}TD) regulates physiologic ligand binding to integrin CD11b/CD18 Blood, April 15, 2007; 109(8): 3513 - 3520. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |